Join us to extend our knowledge of the safety profile of IXCHIQ (Chikungunya vaccine, live)

This study aims to investigate IXCHIQ’s safety in real world conditions and to gather data in populations underrepresented or excluded in clinical trials.

After routine vaccination with IXCHIQ, eligible individuals will be invited to participate in the study within 5 days of vaccination.

Individuals will be provided with adequate time to have questions answered prior to consenting to participate via a mobile app.

Participants will need to provide proof of an IXCHIQ vaccination and complete a baseline questionnaire.

Eligible participants will be requested to complete questionnaires asking safety follow-up questions at days 7, 14, 30, 45, 60, 90, 120 and 168 from date of vaccination via a mobile app.

If you are pregnant and received IXCHIQ you may decide to participate in a pregnancy exposure registry by calling 1-855-417-6214 or by visiting https://www.valneva-oxon.com/IXCHIQPregnancyRegistry.

{{ failureMessage }}

Register below if you are interested in participating

{{ errors.email[0] }}
{{ errors.first_name[0] }}
{{ errors.last_name[0] }}
{{ errors.state[0] }}

Participant benefits

  • Enrolled participants will be compensated for their participation.
  • Opt out at any time.
To learn more about how we safeguard your data, please refer to our Privacy Policy
Have you received IXCHIQ within the last 5 days?
loading...